
KEY POINTS
- India's pharmaceutical industry is currently valued at $50 billion and will likely exceed $130 billion by 2030
- New Delhi has been heavily reliant on cheap APIs from China
- Big biotech companies are eyeing Indian manufacturers for drug development
India's global market share in the pharmaceutical business will grow as the industry, currently valued at $50 billion, is expected to exceed $130 billion by 2030.